PREVENTION SPOTLIGHT: HER2 May Be Biomarker of Kidney Disease in Children, Teens with Lupus, Study Suggests
High levels of a protein called HER2 in the urine can help identify children and adolescents with
lupus
who are at risk of serious kidney complications, a study suggests.
While the study is still ongoing, the finding suggests that the use of approved HER2 inhibitors such as Tyverb (
lapatinib) or Herceptin (
trastuzumab) may also be beneficial for
pediatric lupus patients. Additional studies are still warranted to further confirm the therapeutic activity of these medicines for lupus patients.
Click the blue button below to read the full article
|